Innovex price target raised to $27 from $20 at Piper Sandler

Piper Sandler raised the firm’s price target on Innovex (INVX) to $27 from $20 and keeps an Overweight rating on the shares. The firm says that while 2025 was a challenge, the industry once again exemplified their tenacity, focusing inward and leaning into new growth avenues. As Piper focuses on 2026, it stays selective, but is encouraged by cyclical tailwinds beginning to mount, including Saudi Arabia/Mexico returning to work and a bottoming U.S. Land market, while Offshore eyes a 2027 recovery.